stella
beta
A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases — Stella
Home
/
NSCLC
/
View on ClinicalTrials.gov
Recruiting
Back to NSCLC trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
Israel
Hadassah Ein Kerem Medical Center, Jerusalem